Archivos: Episodio

AMA Update 124: The FDA on Paxlovid and COVID-19: What physicians need to know, Part II

In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.

Read More

MDS Podcast Neuropsychiatric features of punding and hobbyism in Parkinson’s disease

Dr. Hugo Morales discusses «Neuropsychiatric Features of Punding and Hobbyism in Parkinson’s Disease,» by Dr. Pedro Barbosa et al., from Movement Disorders Clinical Practice. Read the article.

Read More

AMA Update 125: Sandra Fryhofer, MD, on what new FDA licensing & authorization requests mean for patients

AMA CXO Todd Unger dives into new developments from ACIP’s emergency meeting on Feb. 4 with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

Read More

Frankly Speaking About Family Medicine Oral Anti−COVID-19 Medications—a Game Changer? – Frankly Speaking Ep 263

Credits: 0.25 AMA PRA Category 1 Credit™   CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-263   Overview: The FDA’s recent emergency use authorization (EUA) for oral agents to treat COVID-19 means that primary care providers (PCPs) will be on the frontline of treating patients with COVID-19. Therefore, PCPs must understand who is eligible for such treatments…

Read More

Medicina Con Cabeza Capítulo 79: Distrofias musculares

Afortunadamente no son unas enfermedades muy frecuentes pero que conviene conocer y que con unos pocos detalles podemos entender y así recordarlas mucho tiempo. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Read More

ScienceLink TOP 2021: Melanoma

La Dra. Florencia Cuadros, oncólogo clínico adscrita al Hospital Eva Perón de Rosario, Argentina y el Dr. Fernando Aldaco, oncólogo médico adscrito al Centro Médico Nacional “20 de Noviembre” ISSSTE de la Ciudad de México, México, nos platican de los estudios y avances más relevantes acerca del melanoma durante el pasado 2021. Neo/adyuvancia KEYNOTE-716 COMBI-APlus…

Read More

De Piel a Cabeza 42. «Reinventarse»: entrevista a Sol Aguirre.

En este episodio entrevistamos a una gran amiga y compañera, Sol Aguirre. Autora del Blog «Las claves de Sol» y autora de varios libros, como “Algún día no es un día de la semana”, «Las primeras veces y otros artículos» y «Todas mis vidas». Sol es…

Read More

Voces por la Salud / Voices for Health, by Roche 27: Mitos y verdades sobre el HPV

¿El cáncer de cuello uterino puede ser prevenible? Conoce la respuesta de la Doctora Lucía Rodich en nuestro episodio «Mitos y verdades sobre el HPV».

Read More

AMA Update 123: The FDA on Monoclonal Antibody Therapeutics: What physicians need to know, Part I

AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed.

Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA

Read More